[go: up one dir, main page]

NO975402L - Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem - Google Patents

Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem

Info

Publication number
NO975402L
NO975402L NO975402A NO975402A NO975402L NO 975402 L NO975402 L NO 975402L NO 975402 A NO975402 A NO 975402A NO 975402 A NO975402 A NO 975402A NO 975402 L NO975402 L NO 975402L
Authority
NO
Norway
Prior art keywords
preparing
methods
pharmaceutical compositions
group
compositions containing
Prior art date
Application number
NO975402A
Other languages
English (en)
Other versions
NO975402D0 (no
Inventor
Timothue Muller
Claudie Moulin
Muriel Duflos
Sylvie Robert-Piessard
Guillaume Le Baut
Alain Tonnerre
Daniel-Henri Caignard
Dominique Manechez
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO975402D0 publication Critical patent/NO975402D0/no
Publication of NO975402L publication Critical patent/NO975402L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører forbindelser med generelle formel (I): O X-N-A-jj-R6 Y O (I) hvor: RI representerer en alkylgruppe, R2, R» og Rs, som kan være identiske eller forskjellige, representerer et hydrogenatom eller en alkylgruppe, R3 representerer hvilken som helst av gruppene som definert i beskrivelsen, X representerer en karbonylgruppe eller en metylengruppe, Y representerer et hydrogenatom eller en alkyl eller arylgruppe, A representerer en enkelbinding eller en alkyl- fenylgruppe, R« representerer hvilket som helst av gruppene som definert i beskrivelsen, deres isomerer samt deres addisjonssalter med en farmasøytisk akseptabel syre eller base.
NO975402A 1996-11-26 1997-11-25 Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem NO975402L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614470A FR2756284B1 (fr) 1996-11-26 1996-11-26 Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO975402D0 NO975402D0 (no) 1997-11-25
NO975402L true NO975402L (no) 1998-05-27

Family

ID=9498038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975402A NO975402L (no) 1996-11-26 1997-11-25 Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem

Country Status (19)

Country Link
US (1) US5889045A (no)
EP (1) EP0844245B1 (no)
JP (1) JPH10158260A (no)
CN (1) CN1183412A (no)
AT (1) ATE201020T1 (no)
AU (1) AU720479B2 (no)
BR (1) BR9705064A (no)
CA (1) CA2222467C (no)
DE (1) DE69704755T2 (no)
DK (1) DK0844245T3 (no)
ES (1) ES2157539T3 (no)
FR (1) FR2756284B1 (no)
GR (1) GR3036242T3 (no)
HU (1) HUP9702227A3 (no)
NO (1) NO975402L (no)
NZ (1) NZ329264A (no)
PL (1) PL323339A1 (no)
PT (1) PT844245E (no)
ZA (1) ZA9710649B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745081B2 (en) * 1997-06-27 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
WO1999043315A1 (fr) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Agent therapeutique utilisable en cas de complication de diabetes
KR100352986B1 (ko) * 2000-04-28 2002-09-18 주식회사 태평양 세라미드 유사 화합물 및 이의 제조방법, 및 이를함유하는 화장료 조성물
WO2004076437A1 (fr) * 2003-02-26 2004-09-10 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Composes de benzopyrane, leur procede de preparation et leurs utilisations
AU2006292352B2 (en) * 2005-09-16 2012-02-09 Cornell Research Foundation, Inc. Methods for reducing CD36 expression
PL2220030T3 (pl) * 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
PT3297625T (pt) 2015-05-22 2022-09-27 Sulfateq Bv Composto para a profilaxia ou tratamento de nefropatia diabética ou doença renal diabética
TW201831471A (zh) 2017-02-24 2018-09-01 盧森堡商艾伯維公司 囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
FR2676056B1 (fr) * 1991-05-03 1993-07-16 Adir Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (no) * 1991-12-14 1995-04-01 Hoechst Ag
ZA93436B (en) * 1992-01-24 1993-08-25 Chugai Pharmaceutical Co Ltd Benzopyran derivatives
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof
US5516917A (en) * 1994-06-08 1996-05-14 G. D. Searle & Co. Leukotriene B4 antagonists
ES2169102T3 (es) * 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
FR2733685B1 (fr) * 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate

Also Published As

Publication number Publication date
NO975402D0 (no) 1997-11-25
CN1183412A (zh) 1998-06-03
FR2756284A1 (fr) 1998-05-29
HUP9702227A3 (en) 1999-03-01
HU9702227D0 (en) 1998-01-28
US5889045A (en) 1999-03-30
ATE201020T1 (de) 2001-05-15
CA2222467A1 (fr) 1998-05-26
AU4538397A (en) 1998-05-28
EP0844245A1 (fr) 1998-05-27
PT844245E (pt) 2001-09-28
NZ329264A (en) 1998-04-27
ES2157539T3 (es) 2001-08-16
HUP9702227A2 (hu) 1998-12-28
BR9705064A (pt) 1999-07-20
PL323339A1 (en) 1998-06-08
ZA9710649B (en) 1998-06-12
GR3036242T3 (en) 2001-10-31
FR2756284B1 (fr) 2000-04-28
EP0844245B1 (fr) 2001-05-09
DK0844245T3 (da) 2001-06-11
JPH10158260A (ja) 1998-06-16
AU720479B2 (en) 2000-06-01
CA2222467C (fr) 2002-05-28
DE69704755D1 (de) 2001-06-13
DE69704755T2 (de) 2002-02-28

Similar Documents

Publication Publication Date Title
DE69904302D1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
ATE250590T1 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
NO20005715L (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
FI941987A0 (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
NO992821L (no) Ketobenzamider som calpain-inhibitorer
CA2054619A1 (en) Aminocoumaran derivatives, their production and use
GEP20094676B (en) Piperidine compounds and pharmaceutical compositions containing them
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
TW248556B (no)
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
DE69828284D1 (de) Naphthyridinderivate oder salze davon
EP1182192A4 (en) 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT
NO992731L (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
NO973213L (no) Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse
GB9715895D0 (en) Heterocyclic compounds
DE69426908D1 (de) Derivate der Phosphonsäure, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
CA2335560A1 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
WO2001079170A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
NO961677L (no) Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
NO950665L (no) Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse
NO20052598L (no) Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.
HUP0004177A2 (hu) 4,5-Diaril-oxazol származékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
NO20002967L (no) Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application